Plain-English translation of NCT07696351 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
China
Phase
Post-approval monitoring
Sponsor
Li-jun Ding
Enrollment target
~120 participants
Started
August 2025
Primary completion
December 2026
Age range
18 Years – 39 Years
Sex
Female only
Last updated on clinicaltrials.gov in July 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jie Mei, PhD
Department of Reproductive Medicine, Nanjing Drum Tower Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.